Growth capital should improve the value of the business a founder owns and its ability to withstand setbacks. The price of that capital includes equity dilution, new decision rights and a different relationship with risk. Founders considering strategic investment need to assess all three together.
From an investor’s perspective, the decisive question is whether additional funding and expertise can generate an attractive return on the capital committed. A persuasive growth story needs a credible route from investment to stronger earnings and cash generation. Founders should apply the same discipline when deciding what ownership and authority they are prepared to share.
As Jamal Khan, Founder and Chairman of Churchill Partners, has said:
“A good investor should strengthen the founder’s vision, not replace it.”
That principle becomes meaningful when the investment plan, governance arrangements and shareholder economics support it.
What growth capital should deliver
Growth capital funds business expansion, including additional capacity, new products, acquisitions or entry into new markets. Growth equity can allow an established business to raise money while its founder retains a majority shareholding. The rights attached to the investment determine how that relationship operates in practice.
Start by separating the company’s funding requirement from the founder’s personal liquidity objective. Primary investment subscribes for new shares and puts money into the business. A secondary share purchase pays an existing shareholder. A transaction can include both, but money paid to a founder does not fund the company’s expansion.
A useful investment proposal therefore specifies where the proceeds go, which milestones they finance and how much liquidity remains if execution takes longer than expected. A large headline investment can still leave a business underfunded when transaction costs, shareholder payments and working capital requirements are overlooked.
Build an investment case around cash generation
Growth earns its place in the investment case when the economics support it. Before raising capital, founders should be able to explain the return expected from each major use of funds and the assumptions on which that return depends.
For a new production facility, this means capacity utilisation, customer demand and the cash tied up in inventory. For an acquisition, it means the price paid, integration costs and the management capacity to deliver improvements. For international expansion, it means a realistic route to customers and the time required to reach cash break-even.
Test the plan under a slower sales ramp, tighter margins and delayed customer payments. Establish when further funding would become necessary. A business that grows turnover while consuming progressively more cash may become more dependent on investors as it scales.
Compare external equity with retaining profits or using an appropriate amount of debt. Borrowing avoids issuing shares, but repayment obligations and lending covenants can constrain flexibility. The right structure depends on the resilience of cash flows and the scale of the opportunity.
Understand how minority investment changes control
Retaining more than half the shares does not settle every question of control. Voting rights, board composition and contractual consent rights can allocate authority differently. Investors may require approval over budgets, acquisitions, new share issues or senior appointments. These provisions should be assessed together.
Founders should establish which decisions management can take within an agreed budget, which require board approval and which need specific investor consent. Clear financial thresholds and a process for resolving disagreements help preserve the speed at which the business needs to operate.
Good governance gives both sides reliable information and an agreed basis for decisions. It also requires founders to accept scrutiny. An investor committing capital will reasonably expect visibility over performance and a voice in material changes to the investment case.
Discuss the founder’s future role explicitly. Remaining a shareholder, remaining chief executive and retaining authority over every operational decision are separate matters. The transaction documents should reflect what has actually been agreed, with advice appropriate to the relevant jurisdiction.
Model founder dilution against the value created
Consider a simplified business with an agreed equity value of £40 million before investment. An investor subscribes £10 million for new ordinary shares. The post-investment equity value is £50 million, giving the investor 20% and leaving a sole founder with 80%. The founder receives no personal cash in this primary investment.
The next step is to compare plausible outcomes over the same period. These illustrative scenarios show why the retained percentage alone is an incomplete measure.
| Illustrative outcome | Future equity value | Founder ownership | Founder stake value |
|---|---|---|---|
| Continue without external equity | £60 million | 100% | £60 million |
| Raise capital and deliver the growth plan | £80 million | 80% | £64 million |
| Raise capital and underperform | £45 million | 80% | £36 million |
Illustration only, not a forecast. Assumes equal economic rights, no further dilution or distributions, and excludes fees and tax. Figures are equity values after allowing for net debt, not enterprise values.
Under these assumptions, the funded business must exceed £75 million of equity value for an 80% holding to be worth more than the £60 million independent outcome. The founder should assess the probability, timing and risk of reaching that threshold. An optimistic valuation scenario is insufficient evidence on its own.
Read the economics behind the headline valuation
Two offers at the same valuation can produce different founder outcomes. A liquidation preference can give an investor priority over specified proceeds. Anti-dilution provisions can alter ownership if a later round is priced lower. An employee option pool can also reduce the founder’s eventual percentage.
Model the actual proceeds payable to each shareholder under strong, moderate and weak outcomes. Include any preference terms, management incentives and further funding. Then examine exit rights: a drag-along can compel shareholders to participate in a sale when agreed conditions are met, while a tag-along can enable them to join a qualifying sale.
This exercise connects the commercial negotiation to what each party may ultimately receive. It should happen while competing proposals can still be compared.
Test what the strategic investor can contribute
The word “strategic” needs evidence. Ask which individuals will support the business, what relevant operating experience they bring and how much time they will commit. Seek references from founders whose businesses missed their original forecasts. Those conversations can reveal how a partner responds when priorities become difficult.
A credible contribution might be recruiting an experienced finance director, improving pricing discipline, integrating acquisitions or opening a specific customer channel. Translate the proposed support into an operating plan with named responsibilities and measurable outcomes.
Where the investor is an industry corporate, assess its commercial objectives alongside the financial terms. Distribution access may be valuable, but exclusivity or restrictions on working with other parties could narrow future choices. Consider the effect on customers, potential investors and eventual buyers.
Match the investment horizon to the business plan
A founder planning a lengthy international expansion needs to understand when the investor expects liquidity. Ask about the capital’s source, holding period, follow-on capacity and any rights that could trigger a sale or repayment. A stated long-term outlook should be reflected in the structure.
Churchill Partners operates with an indefinite ownership horizon and without a predefined exit timetable. Our model combines patient ownership with operational support and governance. This allows investment decisions to be considered over the period needed to develop the business.
Patient capital still requires performance discipline. Founders and investors should agree how progress will be measured, when the strategy will be reviewed and how future liquidity needs will be addressed.
Questions to resolve before accepting investment
- What can the business achieve independently, and what specifically changes with external capital?
- How much money reaches the company, and what milestones does it fund?
- Which decisions will the founder continue to make, and where will authority be shared?
- What happens to ownership, funding and leadership if performance falls short?
- How and when can each shareholder realise value, and are those expectations compatible?
Clear answers make it easier to judge whether a proposal supports the company’s next stage. If the investment cannot demonstrate a credible improvement in the founder’s prospective outcome, continuing independently remains a valid commercial decision.
The Churchill Partners perspective
At Churchill Partners, our investment strategy focuses on established, EBITDA-positive businesses with defensible positions and international growth potential. Our published criteria target EBITDA of US$10 million or more across sectors including energy, healthcare, aerospace and defence, technology and engineering.
Our Operating Partner and governance model brings relevant sector experience into the ownership relationship, with Operating Partners engaged according to the transaction. The objective is to strengthen the business’s capacity to execute and create enduring value.
If you are considering strategic investment or the next phase of ownership, explore our investment strategy or contact Churchill Partners for a confidential discussion.
Frequently asked questions
Can founders raise growth capital and retain control?
Yes, minority equity investment can leave founders with majority ownership. Their practical authority depends on voting rights, board arrangements and investor consent provisions, which should be reviewed together.
Is growth capital the same as selling a business?
Growth capital funds expansion. A sale transfers existing shares or assets to a buyer. One transaction can combine new company funding with a partial founder exit, so the allocation of proceeds matters.
How much equity should a founder give up?
There is no universal percentage. It depends on valuation, funding needs, share rights and the expected value created. Assess the founder’s potential proceeds under several scenarios, including future dilution.
What makes an investor a good strategic partner?
Relevant operating capability, compatible expectations and clear decision rights. Founders should test the promised contribution against specific business needs and examine how the investor has behaved during setbacks.
